An observational study assessing the prevalence of lumbosacral spinal urate deposition in patients with tophaceous and non-tophaceous gout compared with non-gout controls using Dual-Energy CT (DECT)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Gout
-
Age: Between 50 years - 80 years
-
Gender: Male or Female
-
Other Inclusion Criteria:
- Subjects who are willing to provide informed consent
- Subjects between the ages of 50 to 80 years old
- Subjects is diagnosed with gout (for gout group)
- Subjects are not receiving urate lowering therapy
- Subjects have palpable and measurable peripheral tophi (for tophaceous gout group)
You may not be eligible for this study if the following are true:
-
- Subjects unable to provide informed consent
- Subjects who are not between the ages of 50 and 80 years of age.
- Subjects who have well-controlled gout with sUA under 6.0 mg/dL for a duration of longer than 6 months at the time of evaluation.
- Subjects with history of active malignancy of the spine.
- Subjects with known history of pseudogout, spondyloarthropathy, or any other inflammatory arthritis.
- Subjects who had prior treatment with pegloticase or other uricase for any reason.
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.